Dileepkumar Veeragoni is a postdoctoral research associate in the Nazira El-Hage Laboratory. His research focuses on neuroinflammatory signaling pathways, impaired autophagy-related cellular responses, and immune senescence associated with HIV, antiretroviral therapies, and opioid exposure. His work aims to uncover molecular mechanisms driving chronic inflammation and neurocognitive dysfunction.
Before joining FIU, Veeragoni conducted research at the University of Kansas Medical Center. He studied neural-cancer communication loops in esophageal adenocarcinoma progression. His work also included identifying resistance-related target proteins and biomarkers, as well as repurposing FDA-approved drugs for the treatment of esophageal adenocarcinoma. He has authored more than 20 peer-reviewed publications and actively contributes to collaborative and translational research initiatives
Research Interest
- HIV infection and viral latency in the central nervous system
- Opioid addiction (morphine, fentanyl), HIV–opioid interactions, and associated comorbidities
- Autophagy, inflammasome signaling, and mechanisms of neurodegeneration
- Aging-related processes, including mitophagy and mitochondrial dysfunction.
See research publications and more on FIU Discovery.
Education
- Ph.D., Biotechnology, Academy of Scientific and Innovative Research at CSIR-Indian Institute of Chemical Technology, India
- MSc, Biotechnology, Kakatiya University, India